Lisa Rybicki

18.6k total citations · 1 hit paper
408 papers, 13.0k citations indexed

About

Lisa Rybicki is a scholar working on Oncology, Hematology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lisa Rybicki has authored 408 papers receiving a total of 13.0k indexed citations (citations by other indexed papers that have themselves been cited), including 153 papers in Oncology, 125 papers in Hematology and 94 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lisa Rybicki's work include Hematopoietic Stem Cell Transplantation (79 papers), Lymphoma Diagnosis and Treatment (43 papers) and Acute Myeloid Leukemia Research (40 papers). Lisa Rybicki is often cited by papers focused on Hematopoietic Stem Cell Transplantation (79 papers), Lymphoma Diagnosis and Treatment (43 papers) and Acute Myeloid Leukemia Research (40 papers). Lisa Rybicki collaborates with scholars based in United States, Canada and Switzerland. Lisa Rybicki's co-authors include Declan Walsh, David J. Adelstein, Sinéad Donnelly, Charis Eng, Jessica L. Mester, Thomas W. Rice, Ronald Sobecks, Mohammed S. Orloff, Brian J. Bolwell and Jerrold P. Saxton and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Gastroenterology.

In The Last Decade

Lisa Rybicki

396 papers receiving 12.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lifetime Cancer Risks in Individuals with GermlinePTENMutations

2012 586 citations Lisa Rybicki et al. profile →

Peers

Countries citing papers authored by Lisa Rybicki

Since Specialization

Citations

This map shows the geographic impact of Lisa Rybicki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Rybicki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Rybicki more than expected).

Fields of papers citing papers by Lisa Rybicki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa Rybicki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Rybicki. The network helps show where Lisa Rybicki may publish in the future.

Co-authorship network of co-authors of Lisa Rybicki

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa Rybicki. A scholar is included among the top collaborators of Lisa Rybicki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa Rybicki. Lisa Rybicki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Pilot Trial of Patient-Reported Outcomes for Acute Graft-Versus-Host-Disease 2023 ·Transplantation and Cellular Therapy ·Sagar S. Patel, Sanghee Hong, Lisa Rybicki, (unknown), Jane Dabney, Matt Kalaycio, Ronald Sobecks, Navneet S. Majhail, Betty K. Hamilton	2
2	Tacrolimus/methotrexate vs tacrolimus/reduced-dose methotrexate/mycophenolate for graft-versus-host disease prevention 2023 ·Blood Advances ·Betty K. Hamilton, Lisa Rybicki, Hong Li, (unknown), (unknown), Matt Kalaycio, Ronald Sobecks, Rabi Hanna, Seth J. Rotz, Robert M. Dean, Aaron T. Gerds, Deepa Jagadeesh, Claudio G. Brunstein, Craig S. Sauter, Edward A. Copelan, Navneet S. Majhail	4
3	Toxicity analysis of busulfan pharmacokinetic therapeutic dose monitoring 2022 ·Journal of Oncology Pharmacy Practice ·(unknown), Theresa Urban, (unknown), Faiz Anwer, Robert M. Dean, Aaron T. Gerds, Betty K. Hamilton, Deepa Jagadeesh, Matt Kalaycio, Jack Khouri, Brad Pohlman, Ronald Sobecks, Allison Winter, Lisa Rybicki, Navneet S. Majhail, Brian T. Hill	1
4	Comparison of the Prognostic Value of Risk Assessment Tools in Allogeneic Hematopoietic Cell Transplantation 2021 ·Transplantation and Cellular Therapy ·(unknown), Lisa Rybicki, (unknown), (unknown), Faiz Anwer, Robert M. Dean, Brian T. Hill, Matt Kalaycio, Jack Khouri, Deepa Jagadeesh, Brad Pohlman, Ronald Sobecks, Allison Winter, Navneet S. Majhail, Betty K. Hamilton	1
5	Secular trends of Blood stream infections in allogeneic hematopoietic cell transplant recipients 72 hours prior to death 2021 ·Transplant Infectious Disease ·(unknown), Gabriel Aleixo, Lisa Rybicki, Navneet S. Majhail, Sherif B. Mossad	2
6	Allogeneic blood or marrow transplantation with haploidentical donor and post-transplantation cyclophosphamide in patients with myelofibrosis: a multicenter study 2021 ·Leukemia ·Siddharth Kunte, Lisa Rybicki, Auro Viswabandya, Roni Tamari, Asad Bashey, Alla Keyzner, Madiha Iqbal, Michael R. Grunwald, Bhagirathbhai Dholaria, Hany Elmariah, (unknown), Anurag K. Singh, Sameem Abedin, Amy E. DeZern, Richard J. Jones, Vikas Gupta, Aaron T. Gerds, Tania Jain	20
7	Severity of acute gastrointestinal graft‐vs‐host disease is associated with incidence of bloodstream infection after adult allogeneic hematopoietic stem cell transplantation 2019 ·Transplant Infectious Disease ·Anita Modi, Lisa Rybicki, Navneet S. Majhail, Sherif B. Mossad	10
8	Breath analysis in gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation 2019 ·Blood Advances ·Betty K. Hamilton, Lisa Rybicki, David Grove, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Aaron T. Gerds, Rabi Hanna, Matt Kalaycio, Ronald Sobecks, Navneet S. Majhail, Raed A. Dweik	7
9	Penicillin allergy skin testing as an antibiotic stewardship intervention reduces alternative antibiotic exposures in hematopoietic stem cell transplant recipients 2019 ·Transplant Infectious Disease ·Anita Modi, Navneet S. Majhail, Lisa Rybicki, Vasilios Athans, (unknown), Pavithra Srinivas, David M. Lang, Ronald Sobecks, Christopher Kovacs	14
10	Evaluation of Corticosteroids for Engraftment Syndrome (ES) Prophylaxis in Patients Undergoing Autologous Hematopoietic Cell Transplantation (AHCT) with High-Dose Melphalan (MEL) 2019 ·Biology of Blood and Marrow Transplantation ·(unknown), Theresa Urban, (unknown), (unknown), (unknown), Robert M. Dean, Aaron T. Gerds, Betty K. Hamilton, Brian T. Hill, Deepa Jagadeesh, Matt Kalaycio, Brad Pohlman, Ronald Sobecks, Lisa Rybicki, Navneet S. Majhail	1
11	Validating the AJCC 8th Edition of the Oral Cavity Cancer Staging System: A Multi-institutional Collaborative Study 2018 ·International Journal of Radiation OncologyBiologyPhysics ·Shlomo A. Koyfman, Nikhil Joshi, Eric Lamarre, C. Jillian Tsai, (unknown), (unknown), (unknown), Lisa Rybicki, Neal Dunlap, Sandro Porceddu, A.I. Ghanem, Farzan Siddiqui, Jimmy J. Caudell, (unknown), J.L. Geiger, Brian B. Burkey, David J. Adelstein, N.M. Woody	3
12	Neutropenic fever during peripheral blood progenitor cell mobilization is associated with decreased CD34+ cell collection and increased apheresis collection days 2017 ·Journal of Clinical Apheresis ·Jack Khouri, Lisa Rybicki, Navneet S. Majhail, Matt Kalaycio, Edward A. Copelan, Brad Pohlman, Brian T. Hill, Robert M. Dean, Aleksandr Lazaryan, Betty K. Hamilton, Steven Andrèsen, Ronald Sobecks, Brian J. Bolwell, Hien Liu	6
13	Conditional Long-Term Survival Among Diffuse Large B-Cell Lymphoma (DLBCL) Patients Treated with Autologous Hematopoietic Cell Transplantation (AHCT) 2017 ·Blood ·(unknown), Lisa Rybicki, Brian J. Bolwell, Mohamed A. Kharfan‐Dabaja, Robert M. Dean, Betty K. Hamilton, Rabi Hanna, Deepa Jagadeesh, Matt Kalaycio, Hien Liu, Brad Pohlman, Ronald Sobecks, Brian T. Hill, Navneet S. Majhail	1
14	Role of clinically determined depth of tumor invasion in the treatment of esophageal carcinoma 2003 ·Journal of Thoracic and Cardiovascular Surgery ·Thomas W. Rice, Eugene H. Blackstone, David J. Adelstein, Gregory Zuccaro, John J. Vargo, John R. Goldblum, Sudish C. Murthy, Malcolm M. DeCamp, Lisa Rybicki	53
15	Refining esophageal cancer staging 2003 ·Journal of Thoracic and Cardiovascular Surgery ·Thomas W. Rice, Eugene H. Blackstone, Lisa Rybicki, David J. Adelstein, Sudish C. Murthy, Malcolm M. DeCamp, John R. Goldblum	122
16	Value of accelerated multimodality therapy in stage IIIA and IIIB non–small cell lung cancer 2003 ·Journal of Thoracic and Cardiovascular Surgery ·Malcolm M. DeCamp, Thomas W. Rice, David J. Adelstein, Mark A. Chidel, Lisa Rybicki, Sudish C. Murthy, Eugene H. Blackstone	29
17	Stage III non–small cell lung cancer and metachronous brain metastases 2002 ·Journal of Thoracic and Cardiovascular Surgery ·Nader Moazami, Thomas W. Rice, Lisa Rybicki, David J. Adelstein, Sudish C. Murthy, Malcolm M. DeCamp, Gene H. Barnett, Mark A. Chidel, John H. Suh, Eugene H. Blackstone	35
18	N1 esophageal carcinoma: The importance of staging and downstaging 2001 ·Journal of Thoracic and Cardiovascular Surgery ·Thomas W. Rice, Eugene H. Blackstone, David J. Adelstein, Gregory Zuccaro, John J. Vargo, John R. Goldblum, Lisa Rybicki, Sudish C. Murthy, Malcolm M. DeCamp	63
19	A unified approach to estimating association measures via a joint generalized linear model for paired binary data 2000 ·Communication in Statistics- Theory and Methods ·Yinsheng Qu, Ming Tan, Lisa Rybicki	13
20	Timed barium esophagogram: A simple physiologic assessment for achalasia 2000 ·Journal of Thoracic and Cardiovascular Surgery ·(unknown), Thomas W. Rice, Mark E. Baker, Malcolm M. DeCamp, Sudish C. Murthy, Lisa Rybicki, Eugene H. Blackstone, Joel E. Richter	61

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact